Interview (in Dutch but subtitled in English) with Paul van Liempt, explaining the NLC – The Healthtech Venture Builder way of bringing science to life.
Recent news
NLC Announces Crowdfunding Campaign
NLC Announces Crowdfunding Campaign as part of a larger €10 Million financing round, of which €6.5 million already raised Amsterdam, 01/10/2023— NLC, the…
Read more
TherageniX and University of Nottingham Awarded £995K
TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration – Novel non-viral gene delivery…
Read more
IPD secures funding of €2.1M to initiate its first-in-human trials for prosthetic joint infections
PRESS RELEASE Amsterdam, July 20, 2023 IPD B.V. (Implant Preservation Devices), a Netherlands-based start-up specializing in the treatment of prosthetic joint infections, raised €2.1…
Read more